Rivaroxaban modulates electrical and mechanical characteristics of left atrium

Journal of Biomedical Science

Volumn 20, Issue 1, 2013, Pages

  Chang, Chien Jung ^a,b   Chen, Yao Chang ^c   Lin, Yung Kuo ^a,d   Huang, Jen Hung ^d   Chen, Shih Ann ^e   Chen, Yi Jen ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Cyclooxygenase; Factor Xa; Nitric oxide synthase; Rivaroxaban

Indexed keywords

AMPHOTERICIN B; CALCIUM CHANNEL L TYPE; DELAYED RECTIFIER POTASSIUM CHANNEL; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; POTASSIUM; RIVAROXABAN; CALCIUM; MORPHOLINE DERIVATIVE; THIOPHENE DERIVATIVE; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIASTOLE; DRUG EFFICACY; HEART LEFT ATRIUM; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART REPOLARIZATION; ION CURRENT; MICROELECTRODE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT; WHOLE CELL PATCH CLAMP; ANIMAL; DRUG EFFECT; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HUMAN; ION TRANSPORT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY VEIN;

ORYCTOLAGUS CUNICULUS;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; CALCIUM; HEART ATRIA; HUMANS; ION TRANSPORT; MALE; MICROELECTRODES; MORPHOLINES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, VOLTAGE-GATED; PULMONARY VEINS; RABBITS; THIOPHENES;

EID: 84874932457     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-20-17     Document Type: Article

References (24)

1. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG, J Am Coll Cardiol 1998 31 1622 1626 (Pubitemid 28273307)
2. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo Contrast. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Nayak HM, Hsia HH, J Cardiovasc Electrophysiol 2005 16 474 477 (Pubitemid 40632478)
3. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin. Rana S, Yang L, Hassanian SM, Rezaie AR, J Cell Biochem 2012 113 977 984
4. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction: role of prostacycline, nitric oxide, and thromboxane A2. Yang Z, Arnet U, Bauer E, Segesser LV, Siebenmann R, Turina M, Luscher TF, Circulation 1994 89 2266 2272 (Pubitemid 24142807)
5. Thrombin induces nitric-oxide synthase via G§ssub§α12/ 13§esub§-coupled protein kinase C-dependent I-κBA phosphorylation and JNK-medicated I-κBA degradation. Kang KW, Choi SY, Cho MK, Lee CH, Kim SG, J Biol Chem 2003 278 17368 17378 (Pubitemid 36799622)
6. Physiology and pathophysiology of proteinase-activated receptors (PARs): PARs in the respiratory system: cellular signaling and physiological/ pathological roles. Kawabata A, Kawao N, J Pharmacol Sci 2005 97 20 24 (Pubitemid 40313095)
7. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Werner Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KAA, Califf RM, ROCKET AF Steering Committee, for the ROCKET AF Investigators, N Engl J Med 2011 365 883 891
8. Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium. Tsai CF, Chen YC, Lin YK, Chen SA, Chen YJ, Basic Res Cardiol 2011 106 163 174
9. Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation. Tsai WC, Chen YC, Lin YK, Chen SA, Chen YJ, Circ Arrhyth Electrophysiol 2011 4 550 559
10. Interactions of aging and hydrogen peroxide on pulmonary vein electrical activity: implications in the pathophysiology of atrial fibrillation. Lin YK, Chen YC, Cheng CC, Lin FZ, Lin CI, Chen SA, Chen YJ, Acta Cardiol Sin 2011 27 109 114
11. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ, Basic Res Cardiol 2011 107 293 303
12. Effect of K201, a novel antiarrhythmic drug on calcium handling and arrhythmogenic activity of pulmonary vein cardiomyocytes. Chen YJ, Chen YC, Wongcharoen W, Lin CI, Chen SA, Br J Pharmacol 2008 153 915 925 (Pubitemid 351328929)
13. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Suenari K, Chen YC, Kao YH, Cheng CC, Lin YK, Chen YJ, Chen SA, Basic Res Cardiol 2011 106 65 74
14. Endothelin-1 modulates the arrhythmogenic activity of pulmonary veins. Udyavar AR, Chen YC, Chen YJ, Cheng CC, Lin CI, Chen SA, J Cardiovasc Electrophysiol 2008 19 285 292 (Pubitemid 351294621)
15. The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. Brandt MC, Priebe L, Bohle T, Sudkamp M, Beuckelmann DJ, J Mol Cell Cardiol 2000 32 1885 1896
16. Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Turpie AGG, Arterioscler Thromb Vasc Biol 2007 27 1238 1247 (Pubitemid 46809411)
17. Rivaroxaban: a new oral factor Xa inhibitor. Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V, Arterioscler Thromb Vasc Biol 2010 30 376 381
18. The role of atrial pressure in spontaneous initiation of atrial fibrillation in the dog. Fedorov VV, Trifonova OP, Glukhov AV, Beloshapko GG, Iushmanova AV, Kardiologiia 2004 44 12 51 63
19. Mechanoelectrical feedback regulates the arrhythmogenic activity of pulmonary veins. Chan SL, Chen YC, Chen YJ, Wangcharoen W, Lee SH, Lin CI, Chen SA, Heart 2007 93 82 88 (Pubitemid 46094061)
20. Nitroprusside modulates pulmonary vein arrhythmogenic activity. Lin YK, Lu YY, Chen YC, Chen YJ, Chen SA, J Biomed Sci 2011 17 20 29
21. Role of stretch-activated channels on the stretch-induced changes of rate atrial myocytes. Youm JB, Han J, Kim N, Zhang YH, Kim E, Joo H, Leem CH, Kim SJ, Cha KA, Earm YE, Prog in Biophysi and Molecu Biol 2006 90 186 206 (Pubitemid 41721051)
22. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor. Kubitza D, Becka M, Voith B, Zuehlsdorf M, Wensing G, Clin Pharmacol Ther 2005 78 412 421 (Pubitemid 41393676)
23. Rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-has no clinically relevant interaction with naproxen. Kubitza D, Becka M, Mueck W, Zuehlsdorf M, Br J Clin Pharmacol 2006 63 469 476
24. Pharmacodynamic and pharmacokinetic basics of rivaroxaban. Kreutz R, Fundam Clin Pharmacol 2012 26 27 32